BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38408788)

  • 1. Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma.
    Che H; Jiang P; Choy LYL; Cheng SH; Peng W; Chan RWY; Liu J; Zhou Q; Lam WKJ; Yu SCY; Lau SL; Leung TY; Wong J; Wong VW; Wong GLH; Chan SL; Chan KCA; Lo YMD
    Genome Res; 2024 Mar; 34(2):189-200. PubMed ID: 38408788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs.
    Zhou Z; Ma ML; Chan RWY; Lam WKJ; Peng W; Gai W; Hu X; Ding SC; Ji L; Zhou Q; Cheung PPH; Yu SCY; Teoh JYC; Szeto CC; Wong J; Wong VWS; Wong GLH; Chan SL; Hui EP; Ma BBY; Chan ATC; Chiu RWK; Chan KCA; Lo YMD; Jiang P
    Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2220982120. PubMed ID: 37075072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclease deficiencies alter plasma cell-free DNA methylation profiles.
    Han DSC; Ni M; Chan RWY; Wong DKL; Hiraki LT; Volpi S; Jiang P; Lui KO; Chan KCA; Chiu RWK; Lo YMD
    Genome Res; 2021 Nov; 31(11):2008-2021. PubMed ID: 34470801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic analysis of cell-free DNA by fragmentomic profiling.
    Zhou Q; Kang G; Jiang P; Qiao R; Lam WKJ; Yu SCY; Ma ML; Ji L; Cheng SH; Gai W; Peng W; Shang H; Chan RWY; Chan SL; Wong GLH; Hiraki LT; Volpi S; Wong VWS; Wong J; Chiu RWK; Chan KCA; Lo YMD
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2209852119. PubMed ID: 36288287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma.
    Yu SCY; Deng J; Qiao R; Cheng SH; Peng W; Lau SL; Choy LYL; Leung TY; Wong J; Wong VW; Wong GLH; Jiang P; Chiu RWK; Chan KCA; Lo YMD
    Clin Chem; 2023 Feb; 69(2):168-179. PubMed ID: 36322427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Free DNA Fragmentomics: The Novel Promising Biomarker.
    Qi T; Pan M; Shi H; Wang L; Bai Y; Ge Q
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
    van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
    EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Free DNA Fragmentomics in Liquid Biopsy.
    Ding SC; Lo YMD
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment Ends of Circulating Microbial DNA as Signatures for Pathogen Detection in Sepsis.
    Wang G; Lam WKJ; Ling L; Ma ML; Ramakrishnan S; Chan DCT; Lee WS; Cheng SH; Chan RWY; Yu SCY; Tse IOL; Wong WT; Jiang P; Chiu RWK; Allen Chan KC; Lo YMD
    Clin Chem; 2023 Feb; 69(2):189-201. PubMed ID: 36576350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB.
    Han DSC; Ni M; Chan RWY; Chan VWH; Lui KO; Chiu RWK; Lo YMD
    Am J Hum Genet; 2020 Feb; 106(2):202-214. PubMed ID: 32004449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection.
    Jin C; Liu X; Zheng W; Su L; Liu Y; Guo X; Gu X; Li H; Xu B; Wang G; Yu J; Zhang Q; Bao D; Wan S; Xu F; Lai X; Liu J; Xing J
    Mol Oncol; 2021 Sep; 15(9):2377-2389. PubMed ID: 34133846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fragmentation patterns of maternal plasma cell-free DNA and its applications in non-invasive prenatal testing.
    Pan M; Chen P; Lu J; Liu Z; Jia E; Ge Q
    Prenat Diagn; 2020 Jul; 40(8):911-917. PubMed ID: 32147843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
    Choy LYL; Peng W; Jiang P; Cheng SH; Yu SCY; Shang H; Olivia Tse OY; Wong J; Wong VWS; Wong GLH; Lam WKJ; Chan SL; Chiu RWK; Chan KCA; Lo YMD
    Clin Chem; 2022 Sep; 68(9):1151-1163. PubMed ID: 35587130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
    Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
    Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating cell-free DNA fragmentation is a stepwise and conserved process linked to apoptosis.
    Zhu D; Wang H; Wu W; Geng S; Zhong G; Li Y; Guo H; Long G; Ren Q; Luan Y; Duan C; Wei B; Ma J; Li S; Zhou J; Mao M
    BMC Biol; 2023 Nov; 21(1):253. PubMed ID: 37953260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
    Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
    BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids.
    Kim J; Hong SP; Lee S; Lee W; Lee D; Kim R; Park YJ; Moon S; Park K; Cha B; Kim JI
    Hum Genomics; 2023 Oct; 17(1):96. PubMed ID: 37898819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of recurrently protected genomic regions in cell-free DNA found in urine.
    Markus H; Zhao J; Contente-Cuomo T; Stephens MD; Raupach E; Odenheimer-Bergman A; Connor S; McDonald BR; Moore B; Hutchins E; McGilvrey M; de la Maza MC; Van Keuren-Jensen K; Pirrotte P; Goel A; Becerra C; Von Hoff DD; Celinski SA; Hingorani P; Murtaza M
    Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics.
    Sanchez C; Roch B; Mazard T; Blache P; Dache ZAA; Pastor B; Pisareva E; Tanos R; Thierry AR
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33571170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.
    Chan RWY; Serpas L; Ni M; Volpi S; Hiraki LT; Tam LS; Rashidfarrokhi A; Wong PCH; Tam LHP; Wang Y; Jiang P; Cheng ASH; Peng W; Han DSC; Tse PPP; Lau PK; Lee WS; Magnasco A; Buti E; Sisirak V; AlMutairi N; Chan KCA; Chiu RWK; Reizis B; Lo YMD
    Am J Hum Genet; 2020 Nov; 107(5):882-894. PubMed ID: 33022220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.